India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,277 Girishkumar Limbabhai Chovatia ₹1,800 Cr
Revenue · FY 2019
₹1.06 Lakh
▼ 99% YoY
Net loss · FY 2019
₹49.53 Lakh
Latest filing
EBITDA · FY 2019
-₹45.91 Lakh
Latest filing
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.4 Cr
Issued & subscribed
Open charges
₹62.85 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
2
Provident fund records
About Ami Drugs Private Limited
Data last updated:
Ami Drugs Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 2011 and has been in existence for over 15 years.
Its director Girishkumar Limbabhai Chovatia is #1,277 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U21001GJ2011PTC063805. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.4 Cr. It is led by directors including Akshay Rajeshbhai Boghara (Whole-Time Director) and Kiranben Girishbhai Chovatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vadodara, Gujarat.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.06 Lakh, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹49.53 Lakh and EBITDA of -₹45.91 Lakh. Revenue has grown at a compounded annual rate (CAGR) of 146% over three years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹62.85 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amibiotech.com.
Company details
CIN U21001GJ2011PTC063805
Registration Number 063805
Incorporation Date 27 January 2011
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
CIN history
Ami Drugs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U21001GJ2011PTC063805, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21001GJ2011PTC063805 | Current |
| U52100GJ2011PTC063805 | Previous |
| U24200GJ2011PTC063805 | Previous |
Key People
Akshay Rajeshbhai Boghara Whole-Time Director Neetaben Bharatkumar Boghara Additional Director Kiranben Girishbhai Chovatia Director Recognitions & Rankings of Ami Drugs
Contact details
Ami Drugs Private Limited's registered office is in Vadodara, Gujarat.
- Social Media
- Registered Address701 To 710 Lilleria 1038 Commercial Hub, Gotri Sevasi 30 Mtr Road Next To Zydex Office, Vadodara, Gujarat, India – 390021
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Ami Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Ami Drugs Private Limited
FY 2025 filings availableAmi Drugs Private Limited reported revenue of ₹1.06 Lakh (down 99% YoY) for FY 2019.
Revenue · FY 2019
₹1.06 Lakh ▼ 99%
Net loss · FY 2019
₹49.53 Lakh
EBITDA · FY 2019
-₹45.91 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 99%
3 years · compounded
▲ 146%
Revenue fell 99% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 146%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.06 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹45.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹49.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ami Drugs Private Limited, buy the company report.
Board of directors of Ami Drugs Private Limited
Ami Drugs has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neetaben Bharatkumar Boghara Also directs: Pranav Overseas LLP | Additional Director | 17 Nov 2025 | 0 Years 11 Months | Current |
| Kiranben Girishbhai Chovatia Also directs: All That Dips Private Limited, Ami Deuteroedge Private Limited, Ami Lifesciences Pvt Ltd and 5 more | Director | 27 Jan 2011 | 15 Years 9 Months | Current |
| Girishkumar Limbabhai Chovatia Also directs: Ami Deuteroedge Private Limited, Ami Lifesciences Pvt Ltd, Ami Drugs and Speciality Chemicals Private Limited and 3 more | Director | 07 Jul 2025 | 1 Years 4 Months | Current |
| Ameeshi Girishkumar Chovatia | Director | 16 Aug 2016 | 10 Years 2 Months | Current |
| Mitul Khodabhai Bhayani | Additional Director | 17 Nov 2025 | 0 Years 11 Months | Current |
| Akshay Rajeshbhai Boghara | Whole-Time Director | 04 Nov 2025 | 1 Years 0 Months | Current |
Charges & borrowings
Open charges
₹62.85 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Oct 2025 | 101178791 | Hdfc Bank Limited | ₹62.85 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ami Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ami Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ami Drugs has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Ami Drugs Private Limited, buy the company report.
Recent activity
Ami Drugs Private Limited has 10 board changes on record since 2011: 6 appointments and 4 cessations. The latest: Mitul Khodabhai Bhayani was appointed as Additional Director on 17 Nov 2025.
Appointed
Mitul Khodabhai Bhayani was appointed as Additional Director.
Appointed
Neetaben Bharatkumar Boghara was appointed as Additional Director.
Appointed
Akshay Rajeshbhai Boghara was appointed as Whole-Time Director.
Ceased
Akshay Rajeshbhai Boghara ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 62.85 Cr with Charge ID 101178791 was registered on 17 Oct 2025.
AGM
Ami Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Girishkumar Limbabhai Chovatia was appointed as Director.
Filing
Ami Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Kiranben Girishbhai Chovatia ceased to be Director.
Ceased
Deep Maheshkumar Lodhari ceased to be Director.
Ceased
Girishkumar Limbabhai Chovatia ceased to be Director.
Appointed
Ameeshi Girishkumar Chovatia was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Ami Drugs is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 January 2011 (15+ years old) and is registered under CIN U21001GJ2011PTC063805.
Ami Drugs has 6 current directors:
- Akshay Rajeshbhai Boghara - Whole-Time Director
- Neetaben Bharatkumar Boghara - Additional Director
- Kiranben Girishbhai Chovatia - Director
- Girishkumar Limbabhai Chovatia - Director
- Ameeshi Girishkumar Chovatia - Director
- Mitul Khodabhai Bhayani - Additional Director
The latest financial statements of Ami Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Ami Drugs has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Ami Drugs is U21001GJ2011PTC063805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ami Drugs was incorporated on 27 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Mitul Khodabhai Bhayani was appointed as Additional Director on 17 Nov 2025. Neetaben Bharatkumar Boghara was appointed as Additional Director on 17 Nov 2025. Akshay Rajeshbhai Boghara was appointed as Whole-Time Director on 04 Nov 2025. Ami Drugs has 10 board changes on record in total.
Ami Drugs can be reached through the website amibiotech.com. Its registered office is in Vadodara, Gujarat, India.
The registered office of Ami Drugs is at 701 To 710 Lilleria 1038 Commercial Hub, Gotri Sevasi 30 Mtr Road Next To Zydex Office, Vadodara, Gujarat, India – 390021.
Ami Drugs operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages